Advanced search
Publication Cover
Biomarkers Volume 17, 2012 - Issue 8
Submit an article Journal homepage
211
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus

Gergely ToldiFirst Department of Pediatrics, Semmelweis University, Budapest, HungaryCorrespondence[email protected]
,
Balázs SzalayDepartment of Laboratory Medicine, Semmelweis University, Budapest, Hungary
,
Gabriella BekőDepartment of Laboratory Medicine, Semmelweis University, Budapest, Hungary
,
Márta BocskaiDepartment of Rheumatology, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary
,
Magdolna DeákDepartment of Rheumatology, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary
,
László KovácsDepartment of Rheumatology, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary
,
Barna VásárhelyiDepartment of Laboratory Medicine, Semmelweis University, Budapest, Hungary
&
Attila BalogDepartment of Rheumatology, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary
 show all
Pages 758-763 | Received 19 Jun 2012, Accepted 06 Sep 2012, Published online: 04 Oct 2012

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Szilárd Burcsár, Gergely Toldi, László Kovács, Balázs Szalay, Barna Vásárhelyi & Attila Balog. (2021) Urine soluble urokinase plasminogen activator receptor as a potential biomarker of lupus nephritis activity. Biomarkers 26:5, pages 443-449.
Read now

Articles from other publishers (19)

Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone & Maria Infantino. (2023) Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Autoimmune Rheumatic and Non Rheumatic Diseases. Journal of Personalized Medicine 13:4, pages 688.
Crossref
Alexia A. Zagouras & W.H. Wilson Tang. (2023) Myocardial Involvement in Systemic Autoimmune Rheumatic Diseases. Rheumatic Disease Clinics of North America 49:1, pages 45-66.
Crossref
Gongjun Tan, Binila Baby, Yuqiu Zhou & Tianfu Wu. (2022) Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus. Frontiers in Immunology 12.
Crossref
Sheraz Butt, Jørgen L. Jeppesen, Line Vinderslev Iversen, Mogens Fenger, Jesper Eugen-Olsen, Charlotte Andersson & Søren Jacobsen. (2021) Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis. PLOS ONE 16:2, pages e0247256.
Crossref
Jolanta Sołtysiak, Jacek Zachwieja, Anna Benedyk, Maria Lewandowska-Stachowiak, Michal Nowicki & Danuta Ostalska-Nowicka. (2018) Circulating suPAR as a biomarker of disease severity in children with proteinuric glomerulonephritis. Minerva Pediatrica 71:1.
Crossref
Gulcan Saylam Kurtipek, Recep Kesli, Fatma Tuncez Akyurek, Fikret Akyurek, Arzu Ataseven & Yuksel Terzi. (2018) Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity. International Journal of Rheumatic Diseases 21:4, pages 866-870.
Crossref
Alessia Faccini, Juan Carlos Kaski & Paolo G. Camici. (2016) Coronary microvascular dysfunction in chronic inflammatory rheumatoid diseases. European Heart Journal 37:23, pages 1799-1806.
Crossref
Takehiko Wada. 2016. Biomarkers in Kidney Disease. Biomarkers in Kidney Disease 623 646 .
C. Autilio, R. Morelli, D. Milardi, G. Grande, R. Marana, A. Pontecorvi, C. Zuppi & S. Baroni. (2015) Soluble urokinase-type plasminogen activator receptor as a putative marker of male accessory gland inflammation. Andrology 3:6, pages 1054-1061.
Crossref
Kim Timmermans, Michiel Vaneker, Gert Jan Scheffer, Pauline Maassen, Stephanie Janssen, Matthijs Kox & Peter Pickkers. (2015) Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patients. Journal of Critical Care 30:3, pages 476-480.
Crossref
W L Whittier & J Reiser. (2015) Lupus nephritis: through the looking-glass. Lupus 24:6, pages 533-535.
Crossref
D D Qin, D Song, J Huang, F Yu & M H Zhao. (2014) Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China. Lupus 24:6, pages 546-557.
Crossref
Helena Enocsson, Christopher Sjöwall & Jonas Wetterö. (2015) Soluble urokinase plasminogen activator receptor—A valuable biomarker in systemic lupus erythematosus?. Clinica Chimica Acta 444, pages 234-241.
Crossref
Tae-Hyun Yoo, Christopher E. Pedigo, Johanna Guzman, Mayrin Correa-Medina, Changli Wei, Rodrigo Villarreal, Alla Mitrofanova, Farah Leclercq, Christian Faul, Jing Li, Matthias Kretzler, Robert G. Nelson, Markku Lehto, Carol Forsblom, Per-Henrik Groop, Jochen Reiser, George William Burke, Alessia Fornoni & Sandra Merscher. (2015) Sphingomyelinase-Like Phosphodiesterase 3b Expression Levels Determine Podocyte Injury Phenotypes in Glomerular Disease. Journal of the American Society of Nephrology 26:1, pages 133-147.
Crossref
Takehiko Wada. 2015. Biomarkers in Kidney Disease. Biomarkers in Kidney Disease 1 24 .
Claudia Mora, Ana Milena Arbeláez, Jorge Enrique Medina, Ana Isabel Ospina, Consuelo Romero Sánchez, Paula Andrea Valencia Toro, Diego Alejandro Jaimes, Rafael Valle Oñate, Santos G. Ana María & John Londoño. (2014) El papel de los anticuerpos anti-cromatina, antiC1q y las fracciones del complemento unidas a células en el diagnóstico precoz de actividad lúpica. Revista Colombiana de Reumatología 21:2, pages 76-83.
Crossref
A. Bazso, T. Bazso, P. Szodoray, G. Poor & E. Kiss. (2013) Aseptic necrosis at multiple localisations in a lupus patient with lymphoma. Osteoporosis International 25:4, pages 1415-1417.
Crossref
Helena Enocsson, Jonas Wetterö, Thomas Skogh & Christopher Sjöwall. (2013) Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus. Translational Research 162:5, pages 287-296.
Crossref
Rutger J. H. Maas, Jeroen K. J. Deegens & Jack F. M. Wetzels. (2013) Serum suPAR in patients with FSGS: trash or treasure?. Pediatric Nephrology 28:7, pages 1041-1048.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.